Pain Management

LAS VEGAS — Results showed implementation of an opioid-sparing pain management protocol may reduce opioid consumption compared with a standard opioid prescription protocol in patients undergoing outpatient shoulder and knee arthroscopy.

LAS VEGAS — In this video from the American Academy of Orthopaedic Surgeons Annual Meeting, Joshua C. Rozell, MD, discussed outcomes of a second perioperative dose of dexamethasone for patients undergoing total knee arthroplasty.

In this issue of Healio Rheumatology, we have touched upon a topic that is incredibly important not only for our field of rheumatology, but for health care in general — namely, the issue of chronic pain and all its dimensions.

This month, our featured roundtable assembled an esteemed panel of experts on pain to help unravel the complexities we face with our patients who have chronic unresponsive pain, often in the setting of systemic immune-mediated disorders.

For more than a decade, the medical community as a whole, and particularly the field of rheumatology, has been trying to move away from opioids for the management of chronic pain — with varying degrees of success.

Treatment with zavegepant 10 mg nasal spray was safe, well-tolerated and provided pain and symptom relief for moderate to severe migraine compared with placebo, according to a study published in The Lancet Neurology.

When it comes to patients with osteoarthritis adopting, much less maintaining, an exercise regimen to improve their condition, most rheumatologists have just one thought: “Easier said than done.”

A virtual reality exercise session might be as effective as telehealth-delivered exercise sessions in providing immediate, short-term pain relief for people with endometriosis, according to study results.

Administering six vs. two doses of ketorolac for pain management after cesarean delivery was associated with fewer opioid orders within 72 hours postpartum, according to a presenter at The Pregnancy Meeting.

In a video interview, Benjamin Schlechter, MD, of Dana-Farber Cancer Institute, spoke about two presentations on using radiation palliatively presented at ASCO Gastrointestinal Cancers Symposium.